Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bilgin Özmen, Dilek Özmen, Zuhal Parildar, Işıl Mutaf & Oya Bayindir. (2007) Serum N-Terminal-pro-B-Type Natriuretic Peptide (NT-pro-BNP) Levels in Hyperthyroidism and Hypothyroidism. Endocrine Research 32:1-2, pages 1-8.
Read now
Read now
Jens Peter Gøtze, Jens Kastrup. (2001) Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology. Scandinavian Journal of Clinical and Laboratory Investigation 61:234, pages 47-51.
Read now
Read now
Articles from other publishers (90)
Maíra Tristão Parra, Isaac Sada, Rebecca Gold, Chantal A. Vella, Candice Price, Iva Miljkovic, Amelia Eastman & Matthew Allison. (2024) Associations between muscle quality and N-terminal pro-B-type natriuretic peptide (NT-proBNP): The multi-ethnic study of atherosclerosis. The American Journal of the Medical Sciences 367:3, pages 160-170.
Crossref
Crossref
Myat Soe Thet, Khun Eaint Hlwar, Khaing Soe Thet, Khin Phue Phue Han & Aung Ye Oo. (2024) Preoperative B-Type Natriuretic Peptides to Predict Postoperative Atrial Fibrillation in Cardiac Surgery: A Systematic Review and Meta-Analysis. Heart, Lung and Circulation 33:1, pages 23-32.
Crossref
Crossref
Belinda J. Dunning, Arno R. Bourgonje, Marian L.C. Bulthuis, Jan Alexander, Jan O. Aaseth, Anders Larsson, Harry van Goor & Urban Alehagen. (2023) Selenium and coenzyme Q10 improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals. Free Radical Biology and Medicine 204, pages 207-214.
Crossref
Crossref
Martin Segeroth, David Jean Winkel, Ivo Strebel, Shan Yang, Jan Gerrit van der Stouwe, Jude Formambuh, Patrick Badertscher, Joshy Cyriac, Jakob Wasserthal, Federico Caobelli, Antonio Madaffari, Pedro Lopez-Ayala, Michael Zellweger, Alexander Sauter, Christian Mueller, Jens Bremerich & Philip Haaf. (2023) Pulmonary transit time of cardiovascular magnetic resonance perfusion scans for quantification of cardiopulmonary haemodynamics. European Heart Journal - Cardiovascular Imaging 24:8, pages 1062-1071.
Crossref
Crossref
Chenlong Jiang, Xiangde Lai, Feng Han, Zhijun Gao, Haixia Yang, Xuan Zhao, Huajie Pang, Bin Qiao, Hua Pei & Qiang Wu. (2023)
Shape dependency of gold nanorods through TMB
2+
-mediated etching for the visual detection of NT-proBNP
. RSC Advances 13:16, pages 10503-10507.
Crossref
Crossref
James Suprapto & William G. Tong. (2023) Sensitive detection of heart-failure biomarkers natriuretic peptides using multi-photon laser wave-mixing spectroscopy. Talanta 253, pages 123859.
Crossref
Crossref
Gen-Min Lin, Donald M. Lloyd-Jones, Laura A. Colangelo, Moyses Szklo, Susan R. Heckbert, Lin Yee Chen, Joao A.C. Lima & Kiang Liu. (2022) Secondhand tobacco smoke exposure, urine cotinine, and risk of incident atrial fibrillation: The multi-ethnic study of atherosclerosis. Progress in Cardiovascular Diseases 74, pages 38-44.
Crossref
Crossref
Monika Sadlonova, Thomas Meyer, Lutz Binder, Rolf Wachter, Frank Edelmann & Christoph Herrmann-Lingen. (2020) Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure. BioPsychoSocial Medicine 14:1.
Crossref
Crossref
Dorin Harpaz, Raymond C. S. Seet, Robert S. Marks & Alfred I. Y. Tok. (2020) B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor. Biosensors 10:9, pages 107.
Crossref
Crossref
Mohammad R. OstovanehKasra MoazzamiKihei YoneyamaBharath A. VenkateshSusan R. Heckbert, Colin O. WuSteven Shea, Wendy S. PostAnnette L. Fitzpatrick, Gregory L. BurkeHossein BahramiOtto A. SanchezLori B. DanielsErin D. MichosDavid A. BluemkeJoão A.C. Lima. (2020) Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA). Hypertension 75:2, pages 316-323.
Crossref
Crossref
Jeanne du Fay de LavallazPatrick BadertscherThomas NestelbergerTobias ZimmermannÒscar MiróEmilio SalgadoMichael ChristNicolas GeigyLouise CullenMartin ThanF. Javier Martin-SanchezSalvatore Di SommaW. Frank PeacockBeata MorawiecJoan WalterRaphael TwerenboldChristian PuelacherDesiree WusslerJasper BoeddinghausLuca KoechlinIvo StrebelDagmar I. KellerJens LohrmannEleni MichouMichael KühneTobias ReichlinChristian MuellerMaria Rubini Giménez, Nikola Kozhuharov, Samyut Shrestha, Lorraine Sazgary, Michael Freese, Kathrin Meissner, Caroline Kulangara, Beate Hartmann, Carine Coehlo, Lydia Joray, Pedro Lopez-Ayala, Tobias Breidthardt, Roland Bingisser, José Bustamante Mandrión, Imke Poepping, Damian Kawecki, Piotr Muzyk, Ewa Nowalany-Kozielska, Jaimi Greenslade, Tracey Hawkins, Katharina Rentsch, Arnold von Eckardstein, Andreas Buser, Wanda Kloos, Jana Steude & Stefan Osswald. (2019) B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope. Circulation 139:21, pages 2403-2418.
Crossref
Crossref
Anirban Sinha, Priya Gopinathan, Yi-Da Chung, Shu-Chu Shiesh & Gwo-Bin Lee. (2019) Simultaneous detection of multiple NT-proBNP clinical samples utilizing an aptamer-based sandwich assay on an integrated microfluidic system. Lab on a Chip 19:9, pages 1676-1685.
Crossref
Crossref
Monika Sadlonova, Thomas Meyer, Lutz Binder, Rolf Wachter, Frank Edelmann & Christoph Herrmann-Lingen. (2019) Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study. Psychoneuroendocrinology 101, pages 272-277.
Crossref
Crossref
Xiaoli Yang, Liping Liu, Qingfang Hao, Deyong Zou, Xiaoli Zhang, Liping Zhang, Hongmei Li, Yong Qiao, Huansheng Zhao & Lei Zhou. (2017) Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood. PLOS ONE 12:2, pages e0171376.
Crossref
Crossref
Giuseppe RengoGennaro PaganoPasquale Perrone FilardiGrazia Daniela FemminellaValentina ParisiAlessandro CannavoDaniela LiccardoKlara KomiciGiuseppina GambinoMaria Loreta D’AmicoClaudio de LuciaStefania PaolilloBruno TrimarcoDino Franco VitaleNicola FerraraWalter J. KochDario Leosco. (2016) Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure. Circulation Research 118:7, pages 1116-1124.
Crossref
Crossref
A. Quinlivan, V. Thakkar, W. Stevens, K. Morrisroe, D. Prior, C. Rabusa, P. Youssef, E. Gabbay, J. Roddy, J. G. Walker, J. Zochling, J. Sahhar, P. Nash, S. Lester, M. Rischmueller, S. M. Proudman & M. Nikpour. (2015) Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal 45:11, pages 1134-1140.
Crossref
Crossref
O.A. Sanchez, D.A. Duprez, H. Bahrami, C.A. Peralta, L.B. Daniels, J.A. Lima, A. Maisel, A.R. Folsom & D.R. Jacobs. (2015) Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes & Metabolism 41:5, pages 378-386.
Crossref
Crossref
Otto A. Sanchez, Daniel A. Duprez, Lori B. Daniels, Alan S. Maisel, James D. Otvos, Carmen A. Peralta, João A. Lima, Hossein Bahrami & David R. JacobsJr.Jr.. (2015) The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis. Metabolism 64:8, pages 857-861.
Crossref
Crossref
Min-Soo Ahn, Byung-Su Yoo, Ji Hyun Lee, Jun-Won Lee, Young Jin Youn, Sung Gyun Ahn, Jang-Young Kim, Seung-Hwan Lee, Junghan Yoon, Jong-ku Park, Song Vogue Ahn & Eunhee Choi. (2015) Addition of N-terminal Pro-B-type Natriuretic Peptide Levels to Electrocardiography Criteria for Detection of Left Ventricular Hypertrophy: The ARIRANG Study. Journal of Korean Medical Science 30:4, pages 407.
Crossref
Crossref
Caroline Kistorp, Henning Bliddal, Jens P Goetze, Robin Christensen & Jens Faber. (2014) Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity. BMC Obesity 1:1.
Crossref
Crossref
Kasper Iversen, Jens P Gøtze, Morten Dalsgaard, Henrik Nielsen, Søren Boesgaard, Morten Bay, Vibeke Kirk, Olav W Nielsen & Lars Køber. (2014) Risk stratification in emergency patients by copeptin. BMC Medicine 12:1.
Crossref
Crossref
Svend A. Mortensen, Franklin Rosenfeldt, Adarsh Kumar, Peter Dolliner, Krzysztof J. Filipiak, Daniel Pella, Urban Alehagen, Günter Steurer & Gian P. Littarru. (2014) The Effect of Coenzyme Q 10 on Morbidity and Mortality in Chronic Heart Failure. JACC: Heart Failure 2:6, pages 641-649.
Crossref
Crossref
Christian D. Peters, Krista D. Kjaergaard, Jens D. Jensen, Kent L. Christensen, Charlotte Strandhave, Ida N. Tietze, Marija K. Novosel, Bo M. Bibby, Lars T. Jensen, Erik Sloth & Bente Jespersen. (2014) No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients. Kidney International 86:3, pages 625-637.
Crossref
Crossref
Simona I. Chisalita, Ulf Dahlström, Hans J. Arnqvist & Urban Alehagen. (2014) Proinsulin and IGFBP-1 predicts mortality in an elderly population. International Journal of Cardiology 174:2, pages 260-267.
Crossref
Crossref
Heidi M Christensen, Morten Schou, Jens P Goetze, Jens Faber, Jan Frystyk, Allan Flyvbjerg & Caroline Kistorp. (2013) Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction. BMC Cardiovascular Disorders 13:1.
Crossref
Crossref
Yvan DevauxMelanie VausortGerry P. McCannJennifer ZangrandoDominic KellyNaveed RazviLu ZhangLeong L. NgDaniel R. WagnerIain B. Squire. (2013) MicroRNA-150. Circulation: Cardiovascular Genetics 6:3, pages 290-298.
Crossref
Crossref
Björn Agvall, Urban Alehagen & Ulf Dahlström. (2014) The benefits of using a heart failure management programme in Swedish primary healthcare. European Journal of Heart Failure 15:2, pages 228-236.
Crossref
Crossref
Louise JN JensenCaroline KistorpMette BjerreIlan RaymondAllan Flyvbjerg. (2011) Plasma calprotectin levels reflect disease severity in patients with chronic heart failure. European Journal of Preventive Cardiology 19:5, pages 999-1004.
Crossref
Crossref
Heidi M. Christensen, Jan Frystyk, Jens Faber, Morten Schou, Allan Flyvbjerg, Per Hildebrandt, Ilan Raymond, Tobias W. Klausen & Caroline Kistorp. (2014) α‐Defensins and outcome in patients with chronic heart failure. European Journal of Heart Failure 14:4, pages 387-394.
Crossref
Crossref
Michael G. Fradley, Martin G. Larson, Susan Cheng, Elizabeth McCabe, Erin Coglianese, Ravi V. Shah, Daniel Levy, Ramachandran S. Vasan & Thomas J. Wang. (2011) Reference Limits for N-Terminal-pro-B-Type Natriuretic Peptide in Healthy Individuals (from the Framingham Heart Study). The American Journal of Cardiology 108:9, pages 1341-1345.
Crossref
Crossref
Jonathan V. Sweedler, Fang Xie & Adriana Bora. 2011. Protein and Peptide Mass Spectrometry in Drug Discovery. Protein and Peptide Mass Spectrometry in Drug Discovery
393
433
.
Philip Haaf, Cathrin Balmelli, Tobias Reichlin, Raphael Twerenbold, Miriam Reiter, Julia Meissner, Nora Schaub, Claudia Stelzig, Michael Freese, Patricia Paniz, Christophe Meune, Beatrice Drexler, Heike Freidank, Katrin Winkler, Willibald Hochholzer & Christian Mueller. (2011) N-terminal Pro B-type Natriuretic Peptide in the Early Evaluation of Suspected Acute Myocardial Infarction. The American Journal of Medicine 124:8, pages 731-739.
Crossref
Crossref
Minna Ala-Kopsala, Anne-Mari Moilanen, Jaana Rysä, Heikki Ruskoaho & Olli Vuolteenaho. (2010) Characterization of Molecular Forms of N-Terminal B-Type Natriuretic Peptide In Vitro. Clinical Chemistry 56:12, pages 1822-1829.
Crossref
Crossref
Micha T. Maeder, Martin H. Brutsche, Andreas Christ, Tobias Reichlin, Daniel Staub, Markus Noveanu, Tobias Breidthardt, Mihael Potocki & Christian Mueller. (2009) Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease. Respiratory Medicine 103:9, pages 1337-1345.
Crossref
Crossref
A. A. Voors, S. von Haehling, S. D. Anker, H. L. Hillege, J. Struck, O. Hartmann, A. Bergmann, I. Squire, D. J. van Veldhuisen & K. Dickstein. (2009) C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. European Heart Journal 30:10, pages 1187-1194.
Crossref
Crossref
Urban Alehagen, Ulf Dahlström & Tomas L. Lindahl. (2009) Cystatin C and NT‐proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10‐year study in primary care. European Journal of Heart Failure 11:4, pages 354-360.
Crossref
Crossref
Urban Alehagen & Ulf Dahlström. (2009) Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure. International Journal of Cardiology 133:2, pages 233-240.
Crossref
Crossref
Juan Ybarra, Francesc Planas, Francesc Navarro-López, Sandra Pujadas, Jaume Pujadas, Jeroni Jurado & Jose M. Pou. (2009) Association between sleep-disordered breathing, aminoterminal pro-brain natriuretic peptide (NT-proBNP) levels and insulin resistance in morbidly obese young women. European Journal of Internal Medicine 20:2, pages 174-181.
Crossref
Crossref
Micha T. Maeder, Peter Ammann, Thomas Münzer, Otto D. Schoch, Wolfgang Korte, Christoph Hürny, Jonathan Myers & Hans Rickli. (2009) Continuous positive airway pressure improves exercise capacity and heart rate recovery in obstructive sleep apnea. International Journal of Cardiology 132:1, pages 75-83.
Crossref
Crossref
Jens Rosenberg, Finn Gustafsson, Willem J. Remme, Günter A. J. Riegger & Per Rossen Hildebrandt. (2008) Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure. Cardiovascular Drugs and Therapy 22:4, pages 305-311.
Crossref
Crossref
Etienne C H J Michielsen, Jaap A Bakker, Roland R J Van Kimmenade, Yigal M Pinto & Marja P Van Dieijen-Visser. (2008) The diagnostic value of serum and urinary NT-proBNP for heart failure. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 45:4, pages 389-394.
Crossref
Crossref
Thomas Kümler, Gunnar Hilmar Gislason, Vibeke Kirk, Morten Bay, Olav W. Nielsen, Lars Køber & Christian Torp‐Pedersen. (2014) Accuracy of a heart failure diagnosis in administrative registers. European Journal of Heart Failure 10:7, pages 658-660.
Crossref
Crossref
Kasper Iversen, Olav Wendelboe Nielsen, Christian Hassager, Soren Boesgaard, Vibeke Kirk, Morten Bay & Henrik Nielsen. (2008) Heart Murmur and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Death in 2977 Consecutive Hospitalized Patients. The American Journal of the Medical Sciences 335:6, pages 444-450.
Crossref
Crossref
Jung-Ju Sir, Woo-Young Chung, Seok-Jae Hwang, Hyun-Jae Kang, Young-Seok Cho, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim, Dae-Won Sohn, Cheol-Ho Kim, Byung-Hee Oh, Young-Bae Park & Yun-Shik Choi. (2008) N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. International Journal of Cardiology 126:3, pages 322-332.
Crossref
Crossref
Bethan Freestone, Finn Gustafsson, Aun Yeong Chong, Pernille Corell, Caroline Kistorp, Per Hildebrandt & Gregory Y.H. Lip. (2008) Influence of Atrial Fibrillation on Plasma Von Willebrand Factor, Soluble E-Selectin, and N-Terminal Pro B-type Natriuretic Peptide Levels in Systolic Heart Failure. Chest 133:5, pages 1203-1208.
Crossref
Crossref
Caroline Kistorp, Aun Y. Chong, Finn Gustafsson, Søren Galatius, Ilan Raymond, Jens Faber, Gregory Y.H. Lip & Per Hildebrandt. (2014) Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes. European Journal of Heart Failure 10:4, pages 380-387.
Crossref
Crossref
Juan YbarraFrancesc PlanasJose M Pou. (2008) Aminoterminal pro-brain natriuretic peptide (NT-proBNP) and sleep-disordered breathing in morbidly obese females: a cross-sectional study. Diabetes and Vascular Disease Research 5:1, pages 19-24.
Crossref
Crossref
U. Alehagen & M. Janzon. (2014) A clinician's experience of using the Cardiac Reader NT‐proBNP point‐of‐care assay in a clinical setting. European Journal of Heart Failure 10:3, pages 260-266.
Crossref
Crossref
Micha T. Maeder, Peter Ammann, Hans Rickli, Otto D. Schoch, Wolfgang Korte, Christoph Hürny, Jonathan Myers & Thomas Münzer. (2007) N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep and Breathing 12:1, pages 7-16.
Crossref
Crossref
Richard D. Mainwaring, Carol Parise, Stanley B. Wright, Andrew L. Juris, Robert A. Achtel & Hessam Fallah. (2007) Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair. The Annals of Thoracic Surgery 84:6, pages 2066-2069.
Crossref
Crossref
Jorge Eduardo Toblli, Alejandra Lombraña, Patricio Duarte & Federico Di Gennaro. (2007) Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency. Journal of the American College of Cardiology 50:17, pages 1657-1665.
Crossref
Crossref
N. Delmotte, U. Kobold, T. Meier, A. Gallusser, A. Strancar & C. G. Huber. (2007) Miniaturized monolithic disks for immunoadsorption of cardiac biomarkers from serum. Analytical and Bioanalytical Chemistry 389:4, pages 1065-1074.
Crossref
Crossref
Lars G. Olsson, Karl Swedberg, John G.F. Cleland, Phillip A. Spark, Michel Komajda, Marco Metra, Christian Torp‐Pedersen, Willem J. Remme, Armin Scherhag & Philip Poole‐Wilson. (2007) Prognostic importance of plasma NT‐pro BNP in chronic heart failure in patients treated with a β‐blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial. European Journal of Heart Failure 9:8, pages 795-801.
Crossref
Crossref
. (2007) N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study. Journal of the American College of Cardiology 49:3, pages 311-319.
Crossref
Crossref
N. Nasser, Z. Perles, A.J.J.T. Rein & A. Nir. (2005) NT-proBNP as a Marker for Persistent Cardiac Disease in Children with History of Dilated Cardiomyopathy and Myocarditis. Pediatric Cardiology 27:1, pages 87-90.
Crossref
Crossref
Angelika Hammerer-Lercher, Gerhard Pölzl, Gerda Falkensammer, Wilma Ludwig, Heike Hügel, Bernd Puschendorf, Otmar Pachinger & Johannes Mair. (2006) B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure. International Journal of Cardiology 106:3, pages 415-417.
Crossref
Crossref
Johannes Mair. 2006. Cardiovascular Biomarkers. Cardiovascular Biomarkers
373
385
.
Daniel Staub, Nils Jonas, Michael J. Zellweger, Charly Nusbaumer, Damian Wild, Matthias E. Pfisterer, Jan Mueller-Brand, André P. Perruchoud & Christian Mueller. (2005) Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. The American Journal of Medicine 118:11, pages 1287.e9-1287.e16.
Crossref
Crossref
Caroline KistorpJens FaberSøren GalatiusFinn GustafssonJan FrystykAllan FlyvbjergPer Hildebrandt. (2005) Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure. Circulation 112:12, pages 1756-1762.
Crossref
Crossref
Mathavakkannan Suresh & Ken Farrington. (2005) Natriuretic Peptides and the Dialysis Patient. Seminars in Dialysis 18:5, pages 409-419.
Crossref
Crossref
Duncan J. CampbellMark WoodwardJohn P. ChalmersSamuel A. ColmanAlicia J. JenkinsBruce E. KempBruce C. NealAnushka PatelStephen W. MacMahon. (2005) Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation 112:1, pages 110-116.
Crossref
Crossref
Shlomo Cohen, Chaim Springer, Avraham Avital, Zeev Perles, Azaria J. J. T. Rein, Zvi Argaman & Amiram Nir. (2005) Amino-Terminal Pro-Brain-Type Natriuretic Peptide: Heart or Lung Disease in Pediatric Respiratory Distress?. Pediatrics 115:5, pages 1347-1350.
Crossref
Crossref
N. H. Andersen, S. H. Poulsen, S. T. Knudsen, L. Heickendorff & C. E. Mogensen. (2004) NT‐proBNP in normoalbuminuric patients with Type 2 diabetes mellitus. Diabetic Medicine 22:2, pages 188-195.
Crossref
Crossref
Fred S Apple, MaryAnn M Murakami, Lesly A Pearce & Charles A Herzog. (2004) Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death. Clinical Chemistry 50:12, pages 2279-2285.
Crossref
Crossref
Minna Ala-Kopsala, Jarkko Magga, Keijo Peuhkurinen, Jaana Leipälä, Heikki Ruskoaho, Juhani Leppäluoto & Olli Vuolteenaho. (2004) Molecular Heterogeneity Has a Major Impact on the Measurement of Circulating N-Terminal Fragments of A- and B-Type Natriuretic Peptides. Clinical Chemistry 50:9, pages 1576-1588.
Crossref
Crossref
Martin Magnusson, Olle Melander, Bo Israelsson, Anders Grubb, Leif Groop & Stefan Jovinge. (2004) Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease. Diabetes Care 27:8, pages 1929-1935.
Crossref
Crossref
Angelika Hammerer-Lercher, Wilma Ludwig, Gerda Falkensammer, Silvana Müller, Elke Neubauer, Bernd Puschendorf, Otmar Pachinger & Johannes Mair. (2004) Natriuretic Peptides as Markers of Mild Forms of Left Ventricular Dysfunction: Effects of Assays on Diagnostic Performance of Markers. Clinical Chemistry 50:7, pages 1174-1183.
Crossref
Crossref
A Nir, B Bar‐Oz, Z Perles, R Brooks, A Korach & AJJT Rein. (2007) N‐terminal pro‐B‐type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatrica 93:5, pages 603-607.
Crossref
Crossref
Franz Hartmann, Milton Packer, Andrew J.S. Coats, Michael B. Fowler, Henry Krum, Paul Mohacsi, Jean L. Rouleau, Michal Tendera, Alain Castaigne, Jürgen Trawinski, Ildiko Amann‐Zalan, Silke Hoersch & Hugo A. Katus. (2004) NT‐proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT‐proBNP substudy. European Journal of Heart Failure 6:3, pages 343-350.
Crossref
Crossref
V. Kirk, M. Bay, J. Parner, K. Krogsgaard, T.M. Herzog, S. Boesgaard, C. Hassager, O.W. Nielsen, J. Aldershvile & H. Nielsen. (2004) N‐terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). European Journal of Heart Failure 6:3, pages 335-341.
Crossref
Crossref
Olav Wendelboe Nielsen, Vibeke Kirk, Morten Bay, Søren Boesgaard & Henrik Nielsen. (2004) Value of N‐terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). European Journal of Heart Failure 6:3, pages 275-279.
Crossref
Crossref
Lene Svendstrup Nielsen, Jens Svanegaard, Niels Anders Klitgaard & Henrik Egeblad. (2004) N‐terminal pro‐brain natriuretic peptide for discriminating between cardiac and non‐cardiac dyspnoea. European Journal of Heart Failure 6:1, pages 63-70.
Crossref
Crossref
Thomas S. Mir, Reinhard Laux, Hans Henning Hellwege, Bozena Liedke, Cornelius Heinze, Helmut von Buelow, Stephanie Läer & Jochen Weil. (2003) Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth. Pediatrics 112:4, pages 896-899.
Crossref
Crossref
Russell J. O'Brien, Iain B. Squire, Bettina Demme, Joan E. Davies & Leong L. Ng. (2003) Pre‐discharge, but not admission, levels of NT‐proBNP predict adverse prognosis following acute LVF. European Journal of Heart Failure 5:4, pages 499-506.
Crossref
Crossref
Richard W Troughton, Christopher M Frampton, Timothy G Yandle, Eric A Espiner, Gary Nicholls & Mark Richards. (2003) Plasma Amino-Terminal B-Type Natriuretic Peptide Measured by Elecsys 2010 Assay in a Trial of Hormone-guided Treatment for Heart Failure. Clinical Chemistry 49:7, pages 1212-1215.
Crossref
Crossref
A. Siebenhofer, L. L. Ng, J. Plank, A. Berghold, R. Hödl & T. R. Pieber. (2003) Plasma N‐terminal pro‐brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy. Diabetic Medicine 20:7, pages 535-539.
Crossref
Crossref
Heikki Ruskoaho. (2003) Cardiac Hormones as Diagnostic Tools in Heart Failure. Endocrine Reviews 24:3, pages 341-356.
Crossref
Crossref
Martin R Cowie & Gustavo F Mendez. (2003) BNP and congestive heart failure. Current Problems in Cardiology 28:4, pages 264-311.
Crossref
Crossref
Torbjørn Omland & Christian Hall. 2003. Cardiac Markers. Cardiac Markers
411
424
.
Leong L. NgIan LokeRussell J. O’BrienIain B. SquireJoan E. Davies. (2002) Plasma Urotensin in Human Systolic Heart Failure. Circulation 106:23, pages 2877-2880.
Crossref
Crossref
Torbjørn OmlandAnita PerssonLeong NgRussel O’BrienThomas KarlssonJohan HerlitzMarianne HartfordKenneth Caidahl. (2002) N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes. Circulation 106:23, pages 2913-2918.
Crossref
Crossref
Thomas S. Mir, Sönke Marohn, Stephanie Läer, Michele Eiselt, Oswin Grollmus & Jochen Weil. (2002) Plasma Concentrations of N-Terminal Pro-Brain Natriuretic Peptide in Control Children From the Neonatal to Adolescent Period and in Children With Congestive Heart Failure. Pediatrics 110:6, pages e76-e76.
Crossref
Crossref
Johannes Mair. (2002) Role of Cardiac Natriuretic Peptide Testing in Heart Failure. Clinical Chemistry 48:7, pages 977-978.
Crossref
Crossref
Jens Peter Goetze, Jens Kastrup, Frants Pedersen & Jens F Rehfeld. (2002) Quantification of Pro-B-Type Natriuretic Peptide and Its Products in Human Plasma by Use of an Analysis Independent of Precursor Processing. Clinical Chemistry 48:7, pages 1035-1042.
Crossref
Crossref
Bjoern A. Groenning, Jens C. Nilsson, Lars Sondergaard, Frants Pedersen, Jürgen Trawinski, Matthias Baumann, Henrik B.W. Larsson & Per R. Hildebrandt. (2002) Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. American Heart Journal 143:5, pages 923-929.
Crossref
Crossref
Christian Zugck, Armin Haunstetter, Carsten Krüger, Robert Kell, Dieter Schellberg, Wolfgang Kübler & Markus Haass. (2002) Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. Journal of the American College of Cardiology 39:10, pages 1615-1622.
Crossref
Crossref
Andreas LuchnerChristian HengstenbergHannelore LöwelJürgen TrawinskiMatthias BaumannGünter A.J. RieggerHeribert SchunkertStephan Holmer. (2002) N-Terminal Pro-Brain Natriuretic Peptide After Myocardial Infarction. Hypertension 39:1, pages 99-104.
Crossref
Crossref
Yuriko Fischer, Karsten Filzmaier, Hugo Stiegler, Jürgen Graf, Simone Fuhs, Andreas Franke, Uwe Janssens & Axel M Gressner. (2001) Evaluation of a New, Rapid Bedside Test for Quantitative Determination of B-Type Natriuretic Peptide. Clinical Chemistry 47:3, pages 591-594.
Crossref
Crossref
Margaret J Evans, John H Livesey, M.Jane Ellis & Timothy G Yandle. (2001) Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clinical Biochemistry 34:2, pages 107-112.
Crossref
Crossref
Aldo Clerico, Silvia Del Ry & Daniela Giannessi. (2000) Measurement of Cardiac Natriuretic Hormones (Atrial Natriuretic Peptide, Brain Natriuretic Peptide, and Related Peptides) in Clinical Practice: The Need for a New Generation of Immunoassay Methods. Clinical Chemistry 46:10, pages 1529-1534.
Crossref
Crossref